National Pharmaceutical Pricing Authority notifies ceiling prices of 33 drugs

The National Pharmaceutical Pricing Authority (NPPA) has notified the ceiling prices of 33 drugs as per the new pharmaceutical pricing policy.

The notification, NPPA officials say, will have only marginal impact on the prices of most of the drugs 1-2 per cent at the most the only exception being formulations on glipizide, an oral anti-diabetic drug whose prices are likely to reduce by 20 per cent or more.

For monocomponent human insulin, prednisolone acetate ophthalmic (a drop used to treat eye allergies) and ozurdex implant (also used in some eye conditions), all imported items, there would be no change in prices.

Please read our terms of use before posting comments
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
comments powered by Disqus